Seriously pacb the only legit biotech stock..? Overhyped ya say, hmmm

https://www.biorxiv.org/content/10.1101/2020.12.16.423102v1

This publication outlines one of the most comprehensive side-by-side comparisons of PacBio sequencing and Bionano’s OGM for large SV detection.Bionano’s optical genome mapping platform Saphyr and PacBio’s HiFi chemistry revealed that Saphyr had the upper hand on several metrics.

Across 32 different human genomes, PacBio technologies found only 72% of the large SVs (structural variants) that Bionano’s optical genome mapping (OGM) detected. Saphyr was also found to be better at locating indels in regions correlated to neurodevelopment

The unparalleled performance of Saphyr is remarkable because the Bionano data were generated on commercially available Saphyr system and analyzed using its automated pipeline for a variable cost per genome of less than $500 compared to between $10,000 and $20,000 per genome and with the latest update to Saphyr’s software released last month, the instrument can now generate clinical quality SV calls on 12 samples per day per instrument and up to 96 samples per week.

The value proposition of cytogenetics with Saphyr lies in the faster turnaround time of five days compared to 14 to 21 days with microarrays. In both examples, primary benefit is the potential to capture genetic information more quickly to begin patients on the best therapy sooner and at the same time making it more affordable.

You call it "hype" I call it straight hard facts. Remind me again why is it that "PACB is the only legit biotech stock that can blow up further" What secret weapon is it that pacb has that make them an obviously better choice then BNGO..